Trailing-twelve-month (TTM) revenue is $5.53 Billion with a year-over-year growth of +7.85%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $1,430,840,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q3 FY2026Period ended 2025-12-31 | $1,957,549,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-03 |
| Q4 FY2026Period ended 2026-03-31 | $1,119,369,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-22 |
| Q1 FY2027Period ended 2026-06-30 | $1,019,531,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $5,527,289,000 |
Current P/S: $10,680,754,260 market capitalization ÷ $5,527,289,000 TTM revenue = 1.93x.
Market capitalization source: FMP quote. Quote observed 2026-09-18T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $1.02B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-19T00:15:34.700Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Direct-to-Consumer | $1.1B | $1.2B | $1.5B | $1.9B | $2.1B | N/A |
| Hoka Brand Segment | $405M | $629M | $926M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20262026-03-31 · USD |
|---|---|
| Non-US | $2.3B |
| UNITED STATES | $3.2B |
$5.53B
$5.53 Billion
+7.85%
vs. $5.12B a year ago (TTM)
+14.84%
5 Year compound annual growth rate
1 Year
+7.85%
3 Year
+14.43%
5 Year
+14.84%
10 Year
+11.65%
15 Year
+11.59%
20 Year
+16.56%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $5.47B | +$486.68M | +9.76% |
| 2025 | $4.99B | +$697.85M | +16.28% |
| 2024 | $4.29B | +$660.48M | +18.21% |
| 2023 | $3.63B | +$476.95M | +15.14% |
| 2022 | $3.15B | +$604.70M | +23.75% |
| 2021 |
TTM Growth
+7.85%
3-Year CAGR
+14.43%
5-Year CAGR
+14.84%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-19T00:15:34.700Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.4B |
| $2.6B |
| Other Wholesale Segment | $69M | $61M | $54M | $60M | $176M | $146M |
|---|
| Sanuk Wholesale Segment | $27M | $30M | $28M | $17M | N/A | N/A |
|---|
| Teva Wholesale Segment | $106M | $129M | $149M | $114M | N/A | N/A |
|---|
| UGG Wholesale Segment | $872M | $1.1B | $1.0B | $1.1B | $1.3B | $2.7B |
|---|
| $2.55B |
| +$412.95M |
| +19.36% |
| 2020 | $2.13B | +$112.25M | +5.56% |
| 2019 | $2.02B | +$117.10M | +6.15% |
| 2018 | $1.90B | +$113.19M | +6.32% |
| 2017 | $1.79B | ($85.05M) | (4.54%) |
